Where have the shorters gone?, page-17

Phase III acne ,,, then FDA approval then the fire works .... google this one PC
Clinuvel on top of the world after FDA approval caps off rise of 4000%
Been a tough ride with BOT , as you mentioned its had some significant Highs over the past 4 years , company needs to update the market more regularly from the Top..... personally I believe there is significant work progressing in the background,,, plenty of Potential Value in here , just needs to be unlocked,, recognised and capitalised on ,, commercialisation of any of the BOT Treatments will show significant returns ,,
They have a cash chest that exceeds some Market Caps of other Biotechs ... Management need to pull finger and expedite Trials ..... possibly lighten the Management Load if there are going to be delays,,, they are only holding the bench down until needed.... Contract them back when required...
Have a healthy size parcel here,,, obviously would like to see the SP back in the 20c range,,, but on positive news with the size of the markets we are talking about ,,upward movement and interest will return.